Recent studies demonstrated that BMMSCs transfected with hepatocyte nuclear factor 4 alpha (HNF-4α) had a better treatment effect than untreated BMMSCs on a CCl4 liver cirrhosis model. The gene discussed is HNF4A; the disease is cirrhosis of liver.